WPI 2265 (Acitretin 22.5 mg)
This pill with imprint "WPI 2265" is Brown, Capsule-shape and has been identified as Acitretin 22.5 mg. It is manufactured by Actavis Pharma, Inc..
Acitretin is used in the treatment of psoriasis; pityriasis rubra pilaris; psoriatic arthritis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 22.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WPI 2265
- Strength:
- 22.5 mg
- Color:
- Brown
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antipsoriatics
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Actavis Pharma, Inc.
More about acitretin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 14 Reviews – Add your own review/rating
- Drug class: antipsoriatics
Consumer resources
Other brands: Soriatane, Soriatane CK
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
